Company intelligence / Profile preview

ANS Pharma

India

Ownership: Private
Development stage: Commercial

Overview

ANS Pharma is a leading business fortnightly publication for the pharmaceutical industry in India. Established in 2018, it has grown to become a significant player by providing quality and reliable pharmaceutical products and services. The company emphasizes value creation through improving global health via its offerings. It has completed around 10 exports with clients across Africa and serves approximately 50 clients[1].

Modalities: small moleculesgeneric pharmaceuticals
Industry: Consulting

Beyond the preview

Go deeper on ANS Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANS Pharma.

Explore the full profile